tukysa.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * Disallow: /sitecore Sitemap: | ||
Meta Tags
| Title | TUKYSA® (tucatinib) tablets | Official Patient |
| Description | Important Safety Learn about TUKYSA® (tucatinib), a treatment option for certain HER2-positive cancers. Please see full indications & Important |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 4.16.2.178 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
tukysa.com Valuation
|
US$12,869,534
Last updated: 2023-05-16 12:05:37
tukysa.com has Semrush global rank of 822,431. tukysa.com has an estimated worth of US$ 12,869,534, based on its estimated Ads revenue. tukysa.com receives approximately 1,484,947 unique visitors each day. Its web server is located in United States, with IP address 4.16.2.178. According to SiteAdvisor, tukysa.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$12,869,534 |
| Daily Ads Revenue | US$11,880 |
| Monthly Ads Revenue | US$356,388 |
| Yearly Ads Revenue | US$4,276,645 |
| Daily Unique Visitors | 98,997 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| tukysa.com. | A | 14399 | IP: 4.16.2.178 |
| tukysa.com. | NS | 14400 | NS Record: dns1.cscdns.net. |
| tukysa.com. | NS | 14400 | NS Record: dns2.cscdns.net. |
| tukysa.com. | TXT | 14400 | TXT Record: d03np1ywz59z6c1p0fw74vg3m421pf6g |
| tukysa.com. | TXT | 14400 | TXT Record: google-site-verification=u7WKlYiY6HuD2gW-2Hv2cHguCro0PrTnkBDUZevbxsU |
HtmlToTextCheckTime:2023-05-16 12:05:37
| HER2+ Metastatic Breast Cancer TUKYSA (tucatinib) is a prescription medicine used to treat adults with a type of breast cancer called human epidermal growth factor receptor-2 (HER2) positive breast cancer. TUKYSA is used with the medicines trastuzumab and capecitabine, when your cancer has spread to other parts of the body such as the brain (metastatic), or cannot be removed by surgery, and you have received one or more anti-HER2 breast cancer treatments. It is not known if TUKYSA is safe and effective in children. Enter site NOW APPROVED RAS Wild-type, HER2+ Metastatic Colorectal Cancer TUKYSA (tucatinib) is a prescription medicine used to treat adults with a type of colorectal cancer called RAS wild-type HER2 positive colorectal cancer. TUKYSA is used with the medicine trastuzumab, when your cancer has spread to other parts of the body (metastatic), or cannot be removed by surgery, and you have received treatment with fluoropyrimidine-, oxaliplatin-, and irinotecan-based |
HTTP Headers
HTTP/1.0 302 Moved Temporarily Location: https://www.tukysa.com/ Server: BigIP Connection: Keep-Alive Content-Length: 0 HTTP/2 200 date: Tue, 25 Jan 2022 11:49:33 GMT content-type: text/html; charset=UTF-8 content-length: 46231 server: Apache last-modified: Tue, 14 Dec 2021 18:45:38 GMT etag: "b497-5d31f9868b880" accept-ranges: bytes x-dispatcher: env=disd01 |
tukysa.com Whois Information
Domain Name: TUKYSA.COM Registry Domain ID: 2322056580_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.corporatedomains.com Registrar URL: http://cscdbs.com Updated Date: 2021-03-21T20:46:37Z Creation Date: 2018-10-16T17:17:40Z Registry Expiry Date: 2023-10-16T17:17:40Z Registrar: CSC Corporate Domains, Inc. Registrar IANA ID: 299 Registrar Abuse Contact Email: domainabuse@cscglobal.com Registrar Abuse Contact Phone: 8887802723 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: DNS1.CSCDNS.NET Name Server: DNS2.CSCDNS.NET DNSSEC: unsigned >>> Last update of whois database: 2022-01-25T08:41:13Z <<< |